We examined the effect of mutations in the V/3 portion of a pigeon cytochrome c (cyto c)-specific V/33 +/Vcz11 + T cell receptor on its ability to recognize cyto c/IE k and various superantigens. The results were consistent with an immunoglobulin-like structure for the receptor V/3 domain and with separate interaction sites on V/3 for conventional antigen and superantigens. An amino acid predicted to lie in CDR1 was critical for cyto c/IE k but not superantigen recognition, while several amino acids predicted to lie in the hypervariable region 4 loop were critical for superantigen but not cyto c/IE k recognition.
T he V domains of the TCR or//3 are similar to those of Igs both in primary amino acid sequence (1) (2) (3) and in the organization of their rearranging gene elements (4) (5) (6) (7) . A great deal is known from x-ray crystallography about the molecular structure of Ig V domains (8) (9) (10) (11) (12) (13) . Several authors have proposed that the conservation of critical amino acids among Ig and TCR V domains predicts that the structure of the TCR V domains will be very similar to those of Ig with Ig light chain corresponding to the TCR ot chain, and heavy chain corresponding to the TCR/3 chain (1-3). The TCR V domains are, therefore, predicted to be formed from a series of antiparallel/3 strands with the loops corresponding to the three Ig CDR regions brought to one face of the domain to form the binding site for antigen/MHC complexes. Some of the/3 strands (C, C', F, G) are predicted to be involved in the interaction between the o~ and/3 V domains and therefore sequestered from the solvent. The other/3 strands (A, B, D, E) in combination with a fourth nonantigen binding loop (hypervariable region 4 [HV4]) 1 between/3 strands D and E are predicted to form a lateral solvent-exposed face.
There are some data directly supporting this Ig model for the TCR V domains. Several laboratories have shown that amino acids important for antigen/MHC recognition in regions of the ot and/3 chain V domains correspond to the CDILs of Ig, especially CDR3 (14) (15) (16) (17) (18) . We (18) (19) (20) and others (21) have demonstrated amino acids in HV4 and in the 1Abbreviations used in this paper: cyto c, cytochrome c; HV4, hypervariable region 4; SE, staphylococcal enterotoxin.
predicted solvent-exposed/3 strand leading up to CDR1 (/3 strand B) are involved in superantigen recognition.
In the current study we examined a TCR specific both for a cytochrome c (cyto c) peptide complexed with IE k and for the bacterial superantigen toxin SEC3. We tested several amino acids for their importance in the recognition of both types of antigen. An allelic residue in CDR1 was shown to be required for cyto c/IE k but not staphylococcal enterotoxin (SE)C3 recognition, while exchange of amino acids in the predicted HV4 loop with those from the closely related V/317 element eliminated SEC3 recognition without affecting cyto c/IE k reactivity. These results provide additional evidence for an Ig model for TCR V domains and further indicate that conventional antigens and superantigens interact with different sites on the TCR V/3 domain.
Materials and Methods
T Cell Hybridomas. The two T cell hybridomas used in these studies were produced as previously described (22, 23) . The first, 5KC-73, was produced from T cells from B10.BK mice immunized with pigeon cyto c in CFA. The hybrid was sdected on the basis of strong reactivity to both pigeon and moth cyto c peptide 88-104 presented by IEk-expressing APC and the presence of a V/33/ Vc~11 § TCR cz/~ as judged by reactivity with the V/33-specific mAb KJ25 (24) , and with the Vcz11-specific mAb RR-8 (25) . A 15 chain loss variant of this hybridoma was produced by first screening random subclones for the absence of surface TCR c~/15 and then screening RNA from the TCR or~B-subclones by the PCR for the absence of V/33 + /3 chain, but not Vex11 + ~ chain, mRNA (26, 27) . The phenotype was confirmed by the reexpression on the surface of TCR o(/13 upon transection of the variant with constructs encoding the complete B chain of 5KC-73 as described below. This transfectant, instead of the original hybridoma, was used as the wild-type control in the experiments presented here.
The second T cell hybridoma, 3QO23-24, was produced from T cells taken from SWR/J mice immunized with chicken (c)OVA and subsequently panned on the V/317a-specific mAb KJ23a (28, 29) . This hybridoma was selected for high reactivity to cOVA presented by IAq APC and for reactivity with KJ23a (28) .
A/K?. A number of APC lines were used in these experiments. An IEk-expressing fibroblast line, DCEK (30) , was used for the presentation of cyto c Peptides. This line and the mutant IE k-/ IA d § B cell lymphoma line, M12.B5 (31), were used for presentation of staphylococcal toxin superantigens. These lines had the advantage that neither presented endogenous mammary tumor virus (MTV) superantigens (SAgs), DCEK because of lack of expression of the MTV SAg genes 02) and M12.B5 because of the lack of a functional IE molecule 01). MTV SAgs were presented by two other cdllines. CH12.1, a B cell lymphoma of C57BL origin (33) , expresses the SAg of MTV9 (34, 35) , which in combination with IE k stimulates VB17 + T cells (29, 36) , but not V/33" T cells. LBB.1, a class II + B cell lymphoma hybridoma produced by fusion of the BALB/c lymphoma, M12, and R.F/J spleen cells (37) , carries SAgs from a large array of MTVs in addition to MTV9, including MTV6 and MTV1, which are identical in sequence (38) and stimuhte both VB17 + (21) and VB3 + (38) T calls.
Antigens. Pigeon cyto c was purchased from Sigma Chemical
Co. (St. Louis, MO). Peptide 88-104 of pigeon and moth cyto c were prepared by the Molecular Resource Center, National Jewish Center for Immunology and Respiratory Medicine. SEA and SEC3 were purchased from Toxin Technology (Madison WI). Recombinant SEB was produced and purified as previously described (39).
11.,2 Production by T Cell Hybridomas. The relative responses of
T cell hybridomas and transfectants to antigenic stimuli were assessed by the amount of IL-2 they produced as previously described using the II.-2-dependent cell line HT-2 (22, 40) .
Introduction of ~8 Chains into B-5KC-73. tLdntroduction of the
TCR o(//9 ~ chain into the ~3 chain loss variant of 5KC-73 was performed as previously described using the expression vector pBDWC~3 (18) . Briefly, cDNA from mRNA prepared from 5KC-73 was used as template in a PCR. The 5' primer 5'-AGGTCG-ACCACCATGGCTACAAGGCTC-Y matched the VB3 leader and contained a SalI site. The Y-primer 5'-GTCACATTTCTCAGA-TCTTC-Y matched the NH2-terminal region of CB and introduced a BgllI site. The VB3 domain-containing PCP, product was cloned into the SalI/BGIlI site of a variant of pTZ18R in which the BamHI site in the multiple cloning site was replaced with a BgllI site. The insert from a clone established to have the correct sequence was subdoned into the SalI/BgllI site of pBDWCB in frame with the CB2 gene and transfected by electroporation into the ~ loss variant of 5KC-73. Transfectants were selected in G418 and one was chosen on the basis of the reexpression of the V~3 + / V(x11 + "ICE (z/~
Introduction of Mutations into the Vd3 of the TCR cr/d of SKC-73.
Mutations were introduced into the 5KC-73 VB3 as previously described (18) . Briefly, an oligonudeotide primer containing the mutation was synthesized for one strand. A primer overlapping the first primer past the mutation was synthesized for the other strand. Using each of these with the primers described above, the 5' and Y portions of the V/33 domain were synthesized by the PCR. The two fragments were fused by using them as a mixed template in a second PCR again using the leader and C/3 primers described above. The fused fragment containing the mutations in a complete VB domain was cloned, sequenced, subcloned into pBDWC/3, and transfected into the 5KC-73 B loss variant as above. Transfectant dories were screened for approximately equal levels of TCR (x//3 measured with KJ25 (anti-V/93) and HAM-597 (anti-C~) (41) mAbs.
Results
Amino Acids in V,83 Important for SEC3 Recognition. In the mouse the V~ dement most dosdy related to V/33 is V/~17. These V/3s are identical in 65% of their amino acids with the differences scattered throughout their primary sequences ( Fig. 1 ). T cells bearing these V/~ dements have sirnilar~ but not identical, specificities for the SE superantigens (45, 46) . Likewise, these elements have similar but not identical specificities for the mouse MTV-encoded SAgs (21, 24, 29, 36, 38) . These points are illustrated in Fig. 2 . Two T cell hybridomas, 5KC-73, bearing V~3 and specific for pigeon cyto c (88-104) plus IE k, and 3QO23-24, bearing VB17 and specific for cOVA plus IAq, were compared for their response to various Staphylococcus aureus and MTV SAgs presented by various class II MHC antigen-presenting lines. Neither hybridoma responded to SEB, but both responded well to SEA presented by either an IEk-transfected fibroblast line or an IAa-expressing B cdl lymphoma. However, the hybridomas differed in their response to SEC3. The V/33 § hybridoma responded wdl to SEC3 presented by either call line, while the response of the V/~17 + hybridoma was reduced ,vS0-fold with the IAa-presenting ceils and absent In general the specificity of a TCR o~//3 for a SAg/MHC complex is determined by the V/3 element of its receptor. Our previous experiments identified amino acids important in SAg recognition in the region of VB predicted to form solvent-exposed/3 strand B and the adjacent HV4 loop (18) (19) (20) . 
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White et al. (Fig. 1) . Therefore, we transfected the fl chain deletion variant of the V/33 + hybridoma with a construct carrying a mutant V/33 + /3 chain in which these seven amino acids were exchanged for those of V/317. The transfectants were tested for their ability to respond to various toxins and MTV SAgs as well as cyto c/IE k. The results are shown in Fig. 3 .
The transfectant with the wild-type V/~3 + /3 chain responded to cyto c peptides plus IE k, as well as to SEA, SEC3, and LBB.1, but not to CH12.1. Replacement of the amino acids in B strand B and in HV4 with those from V~17 had no effect on the response of the transfectant to cyto c/IE k, SEA, or LBB.1. However, the response to SEC3 was reduced by these substitutions even more dramatically than seen with V/~17 itself (Fig. 2) . These results pinpointed amino acids in putative/3 strand B and/or HV4 as important in SEC3 recognition and confirmed that extensive nonconservative mutations in these regions have no effect on the recognition of conventional peptide antigen bound to MHC class II.
Perhaps unexpectedly, conversion of these seven amino adds of V/~3 to those of V~17 did not transfer the V/~17 reactivity to the MTV9 SAg of CH12.1, indicating that the amino acids in these positions may be necessary, but are not sufficient, for recognition on this MTV SAg.
To pinpoint the amino acids essential for SEC3 recognition we exchanged the three amino acids in B strand B and the four amino acids in HV4 separately and in addition exchanged pairs of amino acids at positions 66 and 74 and at positions 68 and 72 of HV4 separately. Again the transfectants were tested for their response to cyto c peptides presented with IE k and to SEA or SEC3 presented by the two antigenpresenting lines. The results are shown in Fig. 4 . Mutation of the three amino acids in/3 strand B alone had no effect on the response to the cyto c peptide, SEA, or SEC3. However, exchange of the four amino acids in HV4 eliminated the response to SEC3 without affecting the response to SEA or to cyto c/IE k. Partial reduction of the response to SEC3 was seen when amino acid pair 66/74 was exchanged, and virtually a complete loss of response was seen with exchange of the 68/72 pair. These results identify HV4 as an essential part of the VB3 recognition site for SEC3.
An Amino Acid in V~3 Important for Cyto c/IE k Recognition, Pigeon cyto c peptide 88-104 is presented in H2 k mice by the IE k molecule and the response is dominated by T cells bearing V/33/Vo~11 (47) (48) (49) . Two allelic forms of the VB3 dement have been identified (Fig. 1) . Most mouse strains, such as B10.BR, carry the VB3b allde, which has a valine at position 29 predicted to lie in CDR1. A few strains (e.g., C57BR, SWR) carry the V~3a allele, which has a phenylalao nine at this position. Gahm et al. and Fry and Matis (43, 49) have reported that H2 k mice carrying VB3a fail to respond to cyto c with the usual dominant V/33/Vo~11 donotypes, suggesting that the valine at position 29 is critical for cyto c/IE k recognition by these clones. To test this idea directly we replaced this amino acid in the/3 chain of 5KC-73 with the phenylalanine of V~3a and tested the ability of the resulting hybridoma to respond to cyto c/IE k and to several superantigens. The results are shown in Fig. 5 . The hybridoma bearing the wild-type V/33b + B chain responded would not be surprising if the V domains of these two molecules had quite different structures. However, a number of authors have argued for an Ig-like structure for the TCR c~/3 V domains based on the conservation of amino acids in positions critical for the backbone structure of Ig V domains (1-3). In addition, there is mounting direct evidence, including that presented here, supporting an Ig-like structure for the TCR cff3 with regions corresponding to the Ig CDR loops involved in peptide antigen/MHC recognition, some 3 strands buried between the Vc~ and Vfl and others together with HV4 forming another solvent-exposed face involved in SAg recognition.
For example, sites for potential N-linked glycosylation are frequent in mouse and human Vo~ and Vfl elements, and a number of these have been shown to be glycosylated in vivo (19, 50, 51) . Glycosylated asparagines of course must be solvent exposed and should be rare on antigen-binding loops.
The Ig model of the TCR odfl predicts that these sites will lie almost exclusively on solvent-exposed fl strands or loops, rather than CDR loops or buried fl strands (C,C',F,G). Likewise, the few amino acids known to be involved in binding of anti-TCg odfl mAbs are predicted by the Ig model to be on solvent-exposed loops (18, 19) .
There are a number of examples now of amino acids that affect peptide antigen/MHC interaction, which lie in the predicted CDR regions. This is particularly true for CDR3 where alterations in the predicted CDR3 of the oL or fl chain have been associated with changes in peptide antigen specificity (14--16) . Recently, the predicted CDR1 region of Vo~ has been implicated in the allo-MHC specificity of a TCR odfl (17) .
We have identified residues at either end of Vfl CDR1 that are important for antigen/MHC interaction. In a previous study (18) a threonine at position 24 of Vf18.2 was found to be critical for recognition of a cOVA peptide with IA b, and in the current study a valine at position 29 of VB3 was essential for response to cyto c plus IE ~. This latter finding confirms the prediction of Gahm et al. (43) .
There is also accumulating evidence that the predicted solvent-exposed HV4 of V3 plays an essential role in the recognition of various types of SAgs complexed to MHC class II. Previously, we have found that residues in this loop are critical for mouse VflS.2 interaction with Mls-1 a, the SAg of MTV7 (18, 19) . In this case residues on the adjacent fl strand B were also found to be important. Casenave et al. (21) have identified an amino acid in the HV4 loop of Vfl17a (72Q) that controls in vivo deletion of Vf117 + T cells by an MTV SAg carried by C57BL/6 mice (mostly likely that of MTV9). We previously found HV4 to be important in the recognition of SEC2 and SEC3 by human V~13.2 (20) , and now in the current study in the recognition of SEC3 by mouse v 3. The picture is not so clear for SAgs. Although SAg binding to MHC appears to be a prerequisite for TCR c~/3 recognition (52) (53) (54) , the recognition is not MHC restricted in the usual sense. A given TCR c~/fl may recognize a particular SAg in association with many different allelic (or in some cases, isotypic or even xenogenic) forms of MHC class II (52) (53) (54) (55) , and UFwardly pointing mutations in the ol-helical barrels of MHC, which interfere with TCR odfl recognition of bound peptide antigen, often have no effect on recognition of bound SAg (56, 57) . These findings in combination with the overriding importance of HV4, rather than the CDRs, in determining SAg interaction raise the possibility that there are few or no essential interactions between TCR odfl and MHC during SAg recognition and that the main function of the MHC is to capture, orient, and perhaps conformationally alter the SAg, thus promoting interaction with the HV4 site.
Several observations could be used to argue against this view. Occasionally amino acid mutations in the TCR o~/fl CDRs (18) and the MHC c~ helices (57) eliminate T cell recognition of a particular SAg/MHC combination. Also sometimes TCR c~/~ with the correct V~ element fails to recognize the appropriate SAg presented by a particular MHC molecule (29, 52) , indicating involvement of ~ chain CDR3 and/or o~ chain CDRs. These results indicate a dose proximity between TCR ol/fl CDR.s and MHC during SAg recognition and could mean that interactions between the side chains of certain amino acids in the MHC and TCR odfl contribute to binding. However, they are just as easily interpreted to mean that these side chain interactions are irrelevant except when they sterically interfere with docking of the HV4-binding site on Vfl with the SAg bound to MHC.
